TODAY'S HEADLINES
Ann Arbor, MI—A study from the University of Michigan, which was recently published in Health Affairs, found that if all eyecare practitioners (ECPs) prescribed Avastin (bevacizumab, Genentech) patient instead of the more-expensive Lucentis (ranibizumab, Genentech) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), Medicare plans could save $18 billion over a 10-year period. » More |
Irvine, CA—The U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel recently determined that the benefits of AcuFocus’ KAMRA inlay outweigh the risks for presbyopic patients. » More |
Coventry, UK—The British Contact Lens Association recently welcomed Susan Bowers as its president for 2014-15. The new president elect is Brian Tompkins. » More |
San Francisco—In honor of Cataract Awareness Month in June, the American Academy of Ophthalmology has provided answers to 250 commonly asked questions about cataracts. » More |
|
CONNECT WITH Optometry Times
Join your colleagues in conversation, respond to hot-topic questions, and stay up to date on breaking news. Like and follow us today! |
 |
» Facebook |
 |
» Twitter |
|